Holen Sie sich die Stockscreener-App
16.10
3.94%
-0.66
Schlusskurs vom Vortag:
$16.76
Offen:
$16.07
24-Stunden-Volumen:
94,222
Relative Volume:
0.96
Marktkapitalisierung:
$239.17M
Einnahmen:
Nettoeinkommen (Verlust:
KGV:
-
EPS:
-
Netto-Cashflow:
1W Leistung:
-7.95%
1M Leistung:
-50.02%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$15.25
$19.17
52-Wochen-Spanne:
$12.95
$38.41
Vogenx Inc Common Stock Stock (VOGX) Company Profile
Firmenname
Vogenx Inc Common Stock
Sektor
Branche
Telefon
-
Adresse
-
Compare VOGX vs VRTX, MRNA, REGN, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VOGX
Vogenx Inc Common Stock
|
16.10 | 239.17M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
Vogenx Inc Common Stock Aktie (VOGX) Neueste Nachrichten
Vogenx Director Peter Pieraccini Granted 50,000 Stock Options at $18.23 Exercise Price - Kalkine Media
155,000 options for Vogenx (VOGX) science chief vest over three years, subject to continued service. - Stock Titan
A director receives 50,000 Vogenx (VOGX) stock options with an $18.23 exercise price. - Stock Titan
Options priced at $18.23 go to Vogenx (VOGX) CFO Steven R. Delmar in a 155,000-option grant. - Stock Titan
Vogenx Director Kenneth John Toombs Submits Initial Form 3 Reporting No Securities Ownership - Kalkine Media
IPO cash gives Vogenx (VOGX) runway amid losses and control weaknesses - Stock Titan
One asset manager group now reports 13% of Vogenx (VOGX) - Stock Titan
Vogenx (VOGX) insiders report 700,000-share stake in new filing - Stock Titan
Vogenx (NASDAQ: VOGX) CFO holds 700K shares plus options - Stock Titan
Vogenx (VOGX) CEO details 1.8M-share stake and option grants - Stock Titan
Vogenx (VOGX) CSO reports options plus 1.8M indirect shares - Stock Titan
Vogenx (VOGX) director holds stock options out to 2036 - Stock Titan
Vogenx (VOGX) director details $0.93–$1.20 stock options - Stock Titan
Vogenx Strengthens Capital Base With IPO Over-Allotment - TipRanks
Jones Served as Sole Book-Running Manager for Vogenx's $81.3 Million Initial Public Offering - PR Newswire
Jones Served as Sole Book-Running Manager for Vogenx's $81.3 Million Initial Public Offering - Nasdaq
Vogenx Announces Closing of Initial Public Offering - Yahoo Finance
Vogenx closes $81.3M IPO at $13 per share, lists on Nasdaq - scanx.trade
Vogenx, Clinical-Stage Biopharmaceutical Developer, Files for NASDAQ IPO - TradingView
Vogenx, Inc. (VOGX) Stock Price, News, Quote & History - Yahoo Finance
Vogenx (VOGX) director reports 26,665 options, 42,735-share note - Stock Titan
VOGX SEC Filings, Aug 12, 2026Vogenx, Inc. Filing Archive - Stock Titan
Vogenx Announces Pricing of Initial Public Offering - Yahoo Finance
Funding Roundup: Braveheart, Attovia, Vogenx All Announce IPO’s - Pharmaceutical Executive
Vogenx, Clinical-Stage Metabolic Disease Therapeutics, Files for Nasdaq Capital Market IPO - TradingView
Vogenx Announces Initial Public Offering Of Common StockSEC Filing - TradingView
Finanzdaten der Vogenx Inc Common Stock-Aktie (VOGX)
Es liegen keine Finanzdaten für Vogenx Inc Common Stock (VOGX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):